| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |